Cardiovascular Risks and Outcomes Among Chinese American Immigrants: Insights From the Multi‐Ethnic Study of Atherosclerosis
Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial
Association of Urinary Metals With Cardiovascular Disease Incidence and All-Cause Mortality in the Multi-Ethnic Study of Atherosclerosis (MESA)
Longitudinal Impacts of High Versus Low Greenness on Cardiovascular Disease Conditions
Major Adverse Cardiovascular Events Following Coronary Artery Stenting by History of Hypertensive Disorder of Pregnancy
Plasma Protein Biomarkers and Long‐Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart Disease
Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations
Smoking Cessation and Incident Cardiovascular Disease
Cardiovascular Reactivity to Mental Stress and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
Heart Disease Mortality in the United States, 1970 to 2022
Sex related differences in efficacy and safety of antithrombotic therapy in patients with coronary artery disease: systematic review and meta-analysis
Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women
Gestational Diabetes and Incident Hospitalization for Cardiovascular Disease: A Nationwide French Cohort Study
Subgroups With Metabolic Syndrome Show Different Association With Ischemic Heart Disease and Stroke; Findings of Iran STEPS Survey 2021
Metabolomic Biomarkers Are Independently Associated With Secondary Adverse Cardiovascular Events in Patients With Coronary Artery Disease
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Frailty and Its Progression With Cardiovascular Disease Risk With Cardiovascular-Kidney-Metabolic Syndrome Stages 1 to 3
